Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 249
YÖKSİS249 OpenAlex0
Projects 24
Books 23
Proceedings 497

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 185
h-index 21 Percentile in Türkiye: 98 Without large collaborations: h 20 · 1 papers #74 of 2,179 at their university by h-index
i10-index
49
Total citations
2,040
Top 1.5% in Türkiye
Per article
11.0
FWCI
1.77
1.00 = world average
World top 1%
4
World top 10%
21

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 197
  • Q1 71 %35.5
  • Q2 52 %26.0
  • Q3 57 %28.5
  • Q4 20 %10.0
WoS (JCR) 190
  • Q1 50 %26.0
  • Q2 33 %17.2
  • Q3 45 %23.4
  • Q4 64 %33.3
TR Index 41 articles
OpenAlex citation percentile
Top 1%4
Top 10%41
Avg · n 365 %56.5
Other counts

Scopus (SJR)

  • Excluding abstracts 195 Q1 69 Q2 52 Q3 57 Q4 20
  • Best Q 197 Q1 71 Q2 51 Q3 56 Q4 19
  • YÖKSİS rows 399

WoS (JCR)

  • Excluding abstracts 188 Q1 48 Q2 33 Q3 45 Q4 64
  • Best Q 190 Q1 50 Q2 33 Q3 45 Q4 62
  • YÖKSİS rows 381

TR Index

  • YÖKSİS rows 76 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

249articles

Journals with publications

126 journals

Showing the first 80 journals (126 in total).

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article filter applied. Journal filter: Journal of Oncology Pharmacy Practice Clear filter ×

Article list

7 / 249 articles

  1. 2023 Niraparib-induced pure red cell aplasia JOURNAL OF ONCOLOGY PHARMACY PRACTICE DOI 10.1177/10781552231197808 3 YÖKSİS records YÖKSİS SJR Q3 JCR Q4 OpenAlex 45.3%
  2. 2022 Current status of biosimilars in Turkey: A survey among medical oncologists. Journal of oncology pharmacy practice DOI 10.1177/10781552211031643 YÖKSİS SJR Q3 JCR Q4 OpenAlex 44.7%
  3. 2022 Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma Turkish Journal of Medical Sciences DOI 10.55730/1300-0144.5496 YÖKSİS SJR Q3 JCR Q4 OpenAlex 70.2%
  4. 2022 Dangerous interaction of bitter melon (Momordica charantia) with pazopanib: A case of acute pancreatitis Journal of Oncology Pharmacy Practice DOI 10.1177/10781552211040725 YÖKSİS SJR Q3 JCR Q4 OpenAlex 62.0%
  5. 2022 Current status of biosimilars in Turkey: A survey among medical oncologists Journal of Oncology Pharmacy Practice DOI 10.1177/10781552211031643 5 YÖKSİS records YÖKSİS SJR Q3 JCR Q4 OpenAlex 45.6%
  6. 2022 Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners DOI 10.1177/10781552221118529 3 YÖKSİS records YÖKSİS SJR Q3 JCR Q4 OpenAlex 68.9%
  7. 2021 A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. JOURNAL OF ONCOLOGY PHARMACY PRACTICE DOI 10.1177/10781552211031304 2 YÖKSİS records YÖKSİS SJR Q3 JCR Q4 OpenAlex 81.9%

← Back to academicians